Improvement in overall survival in a randomized study that compared dacomitinib with gefitinib in patients with advanced non–small-cell lung cancer and EGFR-activating mutations

1. Mok, T.S.
2. Cheng, Y.
3. Zhou, X.
4. Lee, K.H.
5. Nakagawa, K.
6. Niho, S.
7. Lee, M.
8. Linke, R.
9. Rosell, R.
10. Corral, J.
11. Migliorino, M.R.
12. Pluzanski, A.
13. Sbar, E.I.
14. Wang, T.
15. White, J.L.
16. Wu, Y.-L.